Overview

The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if sexual dysfunction symptoms and quality of life measures in patients with Multiple Sclerosis may be improved in patients that are prescribed Tysabri.
Phase:
N/A
Details
Lead Sponsor:
University of South Florida
Treatments:
Natalizumab